FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management
Up | AC Home Page


Antiviral Drugs Advisory Committee 

October 19-20, 2006


Presentations, discussion, and questions will focus on clinical trial design issues in the development of products for the treatment of chronic hepatitis C infection.  This meeting is being convened in response to the growing number of products in development for this indication. The primary objectives for the committee deliberations are to discuss issues relating to the identification of appropriate control arms, populations for study, endpoints, and long-term follow-up.


FDA Introductory Remarks Hepatitis C: Perspective on Drug Development Issues, Debra Birnkrant, M.D. Director, Division of Antiviral Products, FDA (PPT) (HTM)

Hepatitis C Epidemiology, Natural History, Impact, and Viral Kinetics, Kenneth E. Sherman, M.D., Ph.D.  Gould Professor of Medicine, Director, Division of Digestive Diseases, University of Cincinnati Medical Center, Cincinnati, Ohio, (PPT) (HTM)

Clinical Experience: Difficulties in Trial Design for Therapeutic Products to Treat Chronic HCV Infection, John M. Vierling, M.D., F.A.C.P. Professor of Medicine and Surgery, Director of Baylor Liver Health, Chief of Hepatology, Baylor College of Medicine, Houston, Texas (PPT) (HTM)

Community perspective, Jules Levin, Executive Director/Founder, National AIDS Treatment Advocacy Project (NATAP) (PPT) (HTM)

Summary of Industry Reposes and Regulatory Perspective, William Tauber, M.D., Medical Officer, Division of Antiviral Products, CDER, FDA (PPT) (HTM)

Open Public Hearing

Janice K. Albrecht, Ph.D., Vice President Hepatology Clinical Research, Schering-Plough Research Institute, Kenilworth, NJ (PPT) (HTM)

Questions (PPT) (HTM)

Up | AC Home Page

Page last updated December 4, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management